RUNX2 regulation in osteoblast differentiation: A possible therapeutic function of the lncRNA and miRNA-mediated network
Differentiation · 2024
DOI: 10.1016/j.diff.2024.100803 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Differentiation, 2024. Verfasst von Pakkath Narayanan Arya und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Core Binding Factor Alpha 1 Subunit, MicroRNAs, Osteoblasts. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 158 Literaturangaben. Gefördert von: Indian Council of Medical Research.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India.
- Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, 603 203, Tamil Nadu, India. Electronic address: selvamun@srmist.edu.in.
Förderung
- Indian Council of Medical Research
Zitieren
APA
Arya, P. N., Saranya, I., & Selvamurugan, N. (2024). RUNX2 regulation in osteoblast differentiation: A possible therapeutic function of the lncRNA and miRNA-mediated network. Differentiation. https://doi.org/10.1016/j.diff.2024.100803
Vancouver
Arya PN, Saranya I, Selvamurugan N. RUNX2 regulation in osteoblast differentiation: A possible therapeutic function of the lncRNA and miRNA-mediated network. Differentiation. 2024. doi:10.1016/j.diff.2024.100803
BibTeX
@article{Arya2024,
author = {Arya, Pakkath Narayanan and Saranya, Iyyappan and Selvamurugan, Nagarajan},
title = {RUNX2 regulation in osteoblast differentiation: A possible therapeutic function of the lncRNA and miRNA-mediated network},
journal = {Differentiation},
year = {2024},
doi = {10.1016/j.diff.2024.100803}
}
EUVIMED